Tag: biotech-firm
-
Ablynx burns more cash in first-quarter on higher R&D costs
(Reuters) – Belgian biotech firm Ablynx said on Thursday it used up more cash than it made in the first quarter, driven by higher external research and development costs. Cash burn is a closely watched figure for rising biotech companies that generate revenue only from development milestone payments, and not drug sales. The group, which…
-
80 percent of world’s city dwellers breathing bad air: UN
Over 80 percent of the world's city dwellers breathe poor quality air, increasing their risk of lung cancer and other life-threatening diseases, a new World Health Organization (WHO) report warned Thursday. “Urban air pollution continues to rise at an alarming rate, wreaking havoc on human health,” Maria Neira, the head of WHO's department of public…
-
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…
-
AstraZeneca buys most of Acerta for $4 billion to add cancer drug
By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…